The fight against cancer has been waging for years and years. Throughout this defiant time of conflict, many people have lost their lives while others have been spared. Cancer is one of the most dangerous diseases known to man and catching it in its early stages is crucial. Have you ever heard of a man named Clay Siegall? The Clay Siegall of this article is one of the most prominent persons in cancer research. He’s a doctor, a scientist and a futurist to some degree. His strong passion for eradicating cancer can’t be questioned, and he has dealt with this disease on a first-hand basis.
Dr. Clay Siegall calls the shots at one of the world’s most advanced-research facilities. This facility is known as Seattle Genetics, and it stands at the forefront of the industry. This man is an old-guard of cancer research, and he has been in the game for over 30 years. Siegall has worked with many of the biggest names in the business, including Bristol Myers Squibb, the National Cancer Institute and the National Institute of Health. Seattle Genetics is a biotech-oncology organization in the Pacific Northwest. There are close to 1,000 employees here, and the organization specializes in developing and commercializing targeted-cancer therapies. These types of therapies are very advanced in nature because they specifically seek-out cancer cells in the body. Once the treatment identifies the cancer cells, it will then attach itself to the cancer cells and provide cell-killing agents.
Rigorous research, drug development and scientific innovation are three of Siegall’s core-principles, and he definitely uses them to the fullest. It would be extremely hard trying to find a more progressive approach to fighting cancer in the 21st century.
Find out more about Clay Siegall: http://www.reuters.com/article/brief-seattle-genetics-ceo-clay-siegalls-idUSFWN1HD0M3